BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27623556)

  • 41. Serum biomarkers for the differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
    Caba O; Diéguez-Castillo C; Martínez-Galán J; González-Cebrián I; Jiménez-Luna C
    World J Gastrointest Oncol; 2023 Feb; 15(2):268-275. PubMed ID: 36908319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma.
    Wakabayashi T; Kawaura Y; Satomura Y; Watanabe H; Motoo Y; Okai T; Sawabu N
    Am J Gastroenterol; 2003 Dec; 98(12):2679-87. PubMed ID: 14687817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis.
    Nishimori I; Miyaji E; Morimoto K; Nagao K; Kamada M; Onishi S
    Gut; 2005 Feb; 54(2):274-81. PubMed ID: 15647194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hybrid kappa\lambda antibody is a new serological marker to diagnose autoimmune pancreatitis and differentiate it from pancreatic cancer.
    Hao M; Li W; Yi L; Yu S; Fan G; Lu T; Yang X; Wang G; Zhang D; Ding J; Zhang K; Zhang R; Lin G; Han Y; Wang L; Li J
    Sci Rep; 2016 Jun; 6():27415. PubMed ID: 27271825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoimmune pancreatitis type-1 associated with intraduct papillary mucinous neoplasm: report of two cases.
    Vaquero EC; Salcedo MT; Cuatrecasas M; De León H; Merino X; Navarro S; Ginès A; Abu-Suboh M; Balsells J; Fernández-Cruz L; Molero X
    Pancreatology; 2014; 14(4):316-8. PubMed ID: 25062884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags.
    Sogawa K; Takano S; Iida F; Satoh M; Tsuchida S; Kawashima Y; Yoshitomi H; Sanda A; Kodera Y; Takizawa H; Mikata R; Ohtsuka M; Shimizu H; Miyazaki M; Yokosuka O; Nomura F
    Br J Cancer; 2016 Oct; 115(8):949-956. PubMed ID: 27657339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The combined measurement of total serum IgG and IgG4 may increase diagnostic sensitivity for autoimmune pancreatitis without sacrificing specificity, compared with IgG4 alone.
    Song TJ; Kim MH; Moon SH; Eum JB; Park DH; Lee SS; Seo DW; Lee SK
    Am J Gastroenterol; 2010 Jul; 105(7):1655-60. PubMed ID: 20010924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimal target b-value on computed diffusion-weighted magnetic resonance imaging for visualization of pancreatic ductal adenocarcinoma and focal autoimmune pancreatitis.
    Ichikawa S; Kromrey ML; Motosugi U; Onishi H
    Abdom Radiol (NY); 2021 Feb; 46(2):636-646. PubMed ID: 32740865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancer.
    Tomaino B; Cappello P; Capello M; Fredolini C; Sperduti I; Migliorini P; Salacone P; Novarino A; Giacobino A; Ciuffreda L; Alessio M; Nisticò P; Scarpa A; Pederzoli P; Zhou W; Petricoin Iii EF; Liotta LA; Giovarelli M; Milella M; Novelli F
    J Proteome Res; 2011 Jan; 10(1):105-12. PubMed ID: 20455595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical strategies for differentiating autoimmune pancreatitis from pancreatic malignancy to avoid unnecessary surgical resection.
    Wu WC; Yao XZ; Jin DY; Wang DS; Lou WH; Qin XY
    J Dig Dis; 2013 Sep; 14(9):500-8. PubMed ID: 23692995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of IgG4 response and autoimmune pancreatitis with intraductal papillary-mucinous neoplasms.
    Hedayat AA; Lisovsky M; Suriawinata AA; Longnecker DS
    Pancreatology; 2017; 17(2):263-266. PubMed ID: 28215485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deep Convolutional Neural Network-Assisted Feature Extraction for Diagnostic Discrimination and Feature Visualization in Pancreatic Ductal Adenocarcinoma (PDAC) versus Autoimmune Pancreatitis (AIP).
    Ziegelmayer S; Kaissis G; Harder F; Jungmann F; Müller T; Makowski M; Braren R
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33322559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoimmune pancreatitis: a systemic immune complex mediated disease.
    Deshpande V; Chicano S; Finkelberg D; Selig MK; Mino-Kenudson M; Brugge WR; Colvin RB; Lauwers GY
    Am J Surg Pathol; 2006 Dec; 30(12):1537-45. PubMed ID: 17122509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravoxel incoherent motion diffusion-weighted imaging of the pancreas: Characterization of benign and malignant pancreatic pathologies.
    Kim B; Lee SS; Sung YS; Cheong H; Byun JH; Kim HJ; Kim JH
    J Magn Reson Imaging; 2017 Jan; 45(1):260-269. PubMed ID: 27273754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models.
    Capello M; Cappello P; Linty FC; Chiarle R; Sperduti I; Novarino A; Salacone P; Mandili G; Naccarati A; Sacerdote C; Beghelli S; Bersani S; Barbi S; Bassi C; Scarpa A; Nisticò P; Giovarelli M; Vineis P; Milella M; Novelli F
    J Hematol Oncol; 2013 Sep; 6():67. PubMed ID: 24010981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum protein signatures differentiating autoimmune pancreatitis versus pancreatic cancer.
    Felix K; Hauck O; Fritz S; Hinz U; Schnölzer M; Kempf T; Warnken U; Michel A; Pawlita M; Werner J
    PLoS One; 2013; 8(12):e82755. PubMed ID: 24349355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential for differential diagnosis of autoimmune pancreatitis and pancreatic cancer using carbonic anhydrase II antibody.
    Hosoda H; Okawa-Takatsuji M; Shinmura W; Hasimoto N; Ozaki Y; Ikeda Y
    Pancreas; 2008 Jul; 37(1):e1-7. PubMed ID: 18580434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer.
    Ghazale A; Chari ST; Smyrk TC; Levy MJ; Topazian MD; Takahashi N; Clain JE; Pearson RK; Pelaez-Luna M; Petersen BT; Vege SS; Farnell MB
    Am J Gastroenterol; 2007 Aug; 102(8):1646-53. PubMed ID: 17555461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Laminin 511 is a target antigen in autoimmune pancreatitis.
    Shiokawa M; Kodama Y; Sekiguchi K; Kuwada T; Tomono T; Kuriyama K; Yamazaki H; Morita T; Marui S; Sogabe Y; Kakiuchi N; Matsumori T; Mima A; Nishikawa Y; Ueda T; Tsuda M; Yamauchi Y; Sakuma Y; Maruno T; Uza N; Tsuruyama T; Mimori T; Seno H; Chiba T
    Sci Transl Med; 2018 Aug; 10(453):. PubMed ID: 30089633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance.
    Deshpande V; Gupta R; Sainani N; Sahani DV; Virk R; Ferrone C; Khosroshahi A; Stone JH; Lauwers GY
    Am J Surg Pathol; 2011 Jan; 35(1):26-35. PubMed ID: 21164284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.